Intra-Cellular Therapies
ITCI
#1816
Rank
A$13.89 B
Marketcap
$131.11
Share price
-0.22%
Change (1 day)
46.92%
Change (1 year)

Intra-Cellular Therapies (ITCI) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : A$0.27 Billion

According to Intra-Cellular Therapies's latest financial reports the company's total liabilities are A$0.27 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Intra-Cellular Therapies - Total liabilities on balance sheet (from 2013 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31A$0.20 B38.5%
2022-12-31A$0.14 B45.99%
2021-12-31A$99.35 M26.38%
2020-12-31A$78.62 M-2.02%
2019-12-31A$80.23 M43.14%
2018-12-31A$56.05 M156.69%
2017-12-31A$21.83 M17.47%
2016-12-31A$18.59 M72.3%
2015-12-31A$10.79 M-16.35%
2014-12-31A$12.89 M68.37%
2013-12-31A$7.66 M180.39%
2013-03-31A$0.02 M
2012-12-31A$2.73 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
A$4.6 M-98.33%๐Ÿ‡บ๐Ÿ‡ธ USA
A$78.41 M-71.55%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.40 B 46.27%๐Ÿ‡บ๐Ÿ‡ธ USA